What is Qventus?
Founded in 2012 and headquartered in Mountain View, California, Qventus is at the forefront of real-time operations for hospitals and health systems. The Qventus platform seamlessly integrates with existing Electronic Health Records (EHRs), leveraging artificial intelligence and behavioral science to proactively identify and predict operational issues before they escalate. It orchestrates critical actions among frontline teams and ancillary services, while also managing accountability to foster continuous improvement in healthcare delivery. The company's focus on operational efficiency and predictive analytics positions it as a key player in transforming healthcare management.
How much funding has Qventus raised?
Qventus has raised a total of $98M across 5 funding rounds:
Other Financing Round
$2M
Series A
$13M
Series B
$30M
Other Financing Round
$50M
Other Financing Round
$3M
Other Financing Round (2015): $2M with participation from Valley Fund and Y Combinator
Series A (2016): $13M led by Valley Fund, Mayfield, and Y Combinator
Series B (2018): $30M supported by Bessemer Venture Partners
Other Financing Round (2022): $50M featuring THL
Other Financing Round (2022): $3M backed by ThedaCare
Key Investors in Qventus
THL
THL Partners is a Boston-based private equity firm that focuses on investing in middle-market growth companies across Financial Technology & Services, Healthcare, and Technology & Business Solutions. The firm partners closely with management teams to build enduring, high-value businesses while aiming to deliver strong returns for its investors.
Bessemer Venture Partners
Bessemer Venture Partners (Bessemer) is a venture capital firm with offices in San Francisco, Redwood City, New York City, Boston, Israel, and India. It was established in 1911 as Bessemer Securities.
Mayfield
Mayfield is a Menlo Park-based venture capital firm that raises dedicated funds to invest in early-stage technology companies, primarily at seed and Series A, backing enterprise, consumer, and infrastructure founders and partnering with them through growth and exit.
What's next for Qventus?
With its recent major strategic investment, Qventus is poised for significant expansion and further development of its AI-driven operational platform. The substantial capital infusion, part of its $98M in total financing, suggests a strong validation of its business model and market potential. This funding will likely fuel advancements in predictive analytics, enhance its integration capabilities with diverse healthcare IT systems, and broaden its market reach. Qventus is expected to deepen its impact on hospital efficiency, patient outcomes, and cost reduction, solidifying its leadership in the health technology space.
See full Qventus company page
